Results 21 to 30 of about 273,179 (295)

Medico-economic impact of thoracoscopy versus thoracotomy in lung cancer: multicentre randomised controlled trial (Lungsco01)

BMC Health Services Research, 2023
Background Lungsco01 is the first study assessing the real benefits and the medico-economic impact of video-thoracoscopy versus open thoracotomy for non-small cell lung cancer in the French context.
Anne-Laure Soilly, Ludwig Serge Aho Glélé, Alain Bernard, Halim Abou Hanna, Marc Filaire, Pierre Magdaleinat, Charles Marty-Ané, François Tronc, Renaud Grima, Jean-Marc Baste, Pascal-Alexandre Thomas, Bertrand Richard De Latour, Arnaud Pforr, Pierre-Benoît Pagès   +13 more
doaj   +1 more source

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations

Frontiers in Public Health, 2021
Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as ...
Hugo C. Turner, Rachel A. Archer, Laura E. Downey, Wanrudee Isaranuwatchai, Wanrudee Isaranuwatchai, Kalipso Chalkidou, Mark Jit, Mark Jit, Yot Teerawattananon, Yot Teerawattananon   +9 more
doaj   +1 more source

Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling

BMC Surgery, 2017
Background The objective was to evaluate cost-utility of bariatric surgery in Germany for a lifetime and 10-year horizon from a health care payer perspective.
Oleg Borisenko, Oliver Mann, Anna Duprée   +2 more
doaj   +1 more source

A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma

BMC Ophthalmology, 2012
Background Economic viability of treatments for primary open-angle glaucoma (POAG) should be assessed objectively to prioritise health care interventions.
Bozzani Fiammetta Maria, Alavi Yasmene, Jofre-Bonet Mireia, Kuper Hannah   +3 more
doaj   +1 more source

Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis

Health Technology Assessment, 2023
Background Severe acute respiratory syndrome coronavirus 2 is the virus that causes coronavirus disease 2019. Over six million deaths worldwide have been associated with coronavirus disease 2019.
Metry Andrew, Pandor Abdullah, Ren Shijie, Shippam Andrea, Clowes Mark, Dark Paul, McMullan Ronan, Stevenson Matt   +7 more
doaj   +1 more source

Economic evaluation of using pesticides to control cutaneous leishmaniasis in Isfahan

Journal of Research in Pharmacy Practice, 2018
Objective: Pesticides have been used as the main part of the national cutaneous leishmaniasis control program for serveral years in Iran. However, the cost-effectiveness of this strategy has not been yet analyzed.
Ehsanallah Jafari, Maryam Moeeni, Reza Fadaei, Reza Rezayatmand   +3 more
doaj   +1 more source

Cost‐utility analysis of radiofrequency ablation versus optimal medical therapy in managing supraventricular tachycardia among Filipinos

Journal of Arrhythmia, 2023
Background Radiofrequency ablation (RFA) is the standard of care in the management of supraventricular tachycardia (SVT). Its cost‐effectiveness in an emerging Asian country has not been studied.
Giselle G. Gervacio, Miharu J. M. Kimwell, Erdie C. Fadreguilan, Denese C. De Guzman, E. A. Gabriel, Clara S. Tolentino, Gladys R. S. David   +6 more
doaj   +1 more source

A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments

Frontiers in Pharmacology, 2021
Background: The disease burden of active tuberculosis (TB) is considerable, but systematic reviews of economic evaluations of active TB treatments are scarce.Methods: PubMed, EMBASE, and the Cochrane Library databases were used to search for articles on ...
Joo-Young Byun, Hye-Lin Kim, Eui-Kyung Lee, Sun-Hong Kwon   +3 more
doaj   +1 more source

The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)

BMC Medical Informatics and Decision Making, 2021
Background Tumor necrosis factor α inhibitors (TNFi) is effective for rheumatoid arthritis (RA) patients who fail to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs).
Juan Zhao, Wei Zhou, Yangfeng Wu, Ping Ji, Li Yang, Xiaoyan Yan, Zhuoli Zhang   +6 more
doaj   +1 more source

Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP)

Global & Regional Health Technology Assessment, 2022
Obiettivo: Questo studio ha lo scopo di valutare il rapporto costo-efficacia di ceftolozano/tazobactam rispetto a meropenem per il trattamento di pazienti con polmonite acquisita in ospedale (HABP) o polmonite associata a ventilazione meccanica (VABP ...
Francesco Saverio Mennini, Martina Paoletti, Chiara Bini, Andrea Marcellusi, Marco Falcone, Massimo Andreoni   +5 more
doaj   +1 more source